Gilde Healthcare
Gilde Healthcare Acquires Majority Stake in Danish Drug Development Consultancy KLIFO to Support International Growth Ambitions
Gilde Healthcare Acquires Majority Stake in Danish Drug Development Consultancy KLIFO to Support International Growth Ambitions
Northern European integrated drug development consultancy aims to further expand service offering and geographical footprint
UTRECHT, the Netherlands and COPENHAGEN, Denmark, May 06, 2021 (GLOBE NEWSWIRE) Gilde Healthcare, a specialized healthcare investor, and KLIFO A/S, a leading Northern European drug development consultancy with significant experience in partnering with biotech and pharmaceutical companies to advance their drug development projects, today announce that Gilde Healthcare’s Private Equity fund has acquired a majority stake in KLIFO. Gilde Healthcare aims to support KLIFO’s growth in the dynamically developing pharma outsourcing sector.
Northern European integrated drug development consultancy aims to further expand service offering and geographical footprintUTRECHT, the Netherlands and COPENHAGEN, Denmark, May 06, 2021 (GLOBE NEWSWIRE)